Sanofi-Aventis (Suisse) SA - Mutagrip, Suspension zur Injektion | | 00373 | | 23 | | Mutagrip | | Suspension zur Injektion | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 15.07.2014 | | |
| Composition | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-179A) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Texas/50/2012 (H3N2)-like: reassortant virus NYMC X-223A) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Massachusetts/2/2012-like: B/Massachusetts/2/2012) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0.05 µg, saccharum nihil, neomycinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | Packungsbestandteile | | Suspension zur Injektion | | | | Active Agent | Dose |
---|
Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-179a) | 15 µg | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/texas/50/2012 (H3N2)-Like: Reassortant Virus nymc X-223a) | 15 µg | Haemagglutininum Influenzae b (Virus-Stamm B/massachusetts/2/2012-Like: B/massachusetts/2/2012) | 15 µg |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
No entries have been found. |
|
|